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  The rapid induction of the c-fos gene 
correlates with phosphorylations of 
histone H3 and HMGN1 by mitogen- and 
stress-activated protein kinases (MSKs). 
We have used a cell-free system to dissect 
the mechanism by which MSK1 
phosphorylates histone H3 within the c-fos 
chromatin. Here we show that the 
reconstituted c-fos chromatin presents a 
strong barrier to histone H3 
phosphorylation by MSK1; however, the 
activators (SRF, Elk-1, CREB, and ATF1) 
bound on their cognate sites recruit MSK1 
to phosphorylate histone H3 at S10 within 
the chromatin. This activator-dependent 
phosphorylation of histone H3 is enhanced 
by HMGN1 and occurs preferentially near 
the promoter region. Among the four 
activators, CREB plays a predominant 
role in MSK1-mediated phosphorylation 
of histone H3, and the phosphorylation of 
S133 in CREB is essential for this process. 
Mutational analyses of MSK1 show that its 
N-terminal inhibition domain (NID) is 
critical for the kinase to phosphorylate 
chromatin-embedded histone H3 in a 
CREB-dependent manner, indicating the 
presence of an intricate regulatory 
network for MSK1-mediated 
phosphorylation of histone H3. 
 
  The proto-oncogene c-fos is an 
immediate-early (IE) gene, which is induced 
by various extracellular stimuli including 
growth factors and cellular stresses. 
Transcription of the c-fos gene is controlled 
by inducible regulatory elements such as 
SRE, which are bound by SRF and Elk-1, 
and FAP-1 and CRE, which are bound by 
CREB and ATF1 (1). Upon cell stimulation, 
the activators become phosphorylated via 
cascades of protein kinases before they 
induce c-fos transcription (1,2). Concomitant 
with the phosphorylation of the activators, 
the c-fos gene also undergoes rapid 
alterations in nucleosomal structure, which 
coincide with posttranslational modifications 
of chromatin proteins, including acetylations 
of histones H3 and H4 as well as 
phosphorylations of histone H3 and 
non-histone chromatin protein HMGN1 (2). 
In particular, phosphorylations of serine 10 in 
histone H3 (H3-S10) and serine 6 in HMGN1 
are called the ‘nucleosomal response’ (3) and 
are likely to play a causal role in the rapid, 
dramatic induction of c-fos transcription 
(3,4). 
  Originally, phosphorylation of H3-S10 
associated with transcriptional induction was 
observed in IE genes including c-fos, c-jun, 
and c-myc (5-7). However, transcription of 
other types of genes appears to involve 
H3-S10 phosphorylation as well. In yeast, 
induction of GCN5-regulated genes is 
controlled by H3-S10 phosphorylation (8,9). 
In flies, heat shock gene loci display dramatic 
H3-S10 phosphorylation during heat 
shock-induced transcription (10). In 
mammals, the murine hsp70 gene also 
undergoes H3-S10 phosphorylation when 
induced by arsenite (11). Follicle-stimulating 
hormone, thyroid hormone, and progesterone 
also induce phosphorylation of H3-S10 to 
regulate their target genes (12-14). Hence, 
phosphorylation of H3-S10 may be a histone 
modification that is more broadly required 
for transcriptional induction. 
  It is now firmly established that 
phosphorylations of histone H3 and HMGN1 
are mediated by mitogen- and stress-activated 
protein kinases (MSK) 1 and 2, two closely 
related serine/threonine kinases that are 
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activated via both the ERK1/2 and p38 MAP 
kinase pathways (15-17). MSK1/2 reside 
almost exclusively in nucleus (15,17), and, 
once activated, they phosphorylate S10 and 
S28 in histone H3 and S6 in HMGN1 (3,4) as 
well as S133 in CREB and S63 in ATF1 
(18,19). Structurally, MSK1/2 are composed 
of two kinase domains, the N- and C-terminal 
kinase domains (NTKD and CTKD), which 
are related to the AGC kinase and CaMK 
families, respectively (15,17). The CTKD is 
phosphorylated by the upstream MAP 
kinases and then activates the NTKD through 
multiple phosphorylations within a single 
MSK polypeptide (20).  
  A puzzling but intriguing aspect of H3-S10 
phosphorylation is that it appears to play 
opposing roles in the regulation of chromatin 
structure during different phases of the cell 
cycle. During mitosis or meiosis, Aurora 
kinases phosphorylate a bulk of H3-S10, 
which in turn facilitates compaction of 
chromatin and transcriptional repression 
(21-23). During interphase, in contrast, 
extracellular stimuli lead eventually to 
phosphorylation of H3-S10 by MSK1/2 in a 
minute fraction of histone H3, in correlation 
with rapid transcriptional induction of a 
subset of genes (23,24). Given the antipodal 
effects of H3-S10 phosphorylation on 
transcription during different phases of the 
cell cycle, the phosphorylation of H3-S10 in 
both phases must be under strict control. 
  To dissect the regulatory mechanism of 
chromatin phosphorylation, we have used a 
cell-free system reconstituted with purified 
activators and kinases as well as the 
recombinant chromatin assembled on the 
natural c-fos promoter (25). This system 
allows analyses of the roles for each factor in 
the regulated phosphorylation of histones 
within the c-fos chromatin. We show that the 
chromatin structure is intrinsically inhibitory 
to MSK1-mediated phosphorylation of 
histone H3; in contrast, Aurora B 
phosphorylates histone H3 within the 
chromatin relatively well, possibly through 
its direct interactions with the tails of core 
histones. The phosphorylation of histone H3 
by MSK1, however, is restored by the 
presence of CREB and, to lesser extent, 
ATF1, but not by the presence of SRF or 
Elk-1. This CREB-dependent 
phosphorylation of histone H3 requires the 
phosphorylation of CREB at S133 and is 
facilitated by HMGN1, a non-histone protein 
involved in chromatin decompaction and 
c-fos induction. Mutational analyses of 
MSK1 show that it possesses a complex 
network of intra-molecular regulations, 
which CREB appears to exploit for the 
regulated phosphorylation of histone H3 
embedded within the c-fos chromatin. 
 
EXPERIMENTAL PROCEDURES 
 
  Antibodies─Antibodies against modified 
residues in histone H2A and H2B were 
purchased from Upstate Biotechnology, and 
anti-phospho-SRF(S103) was purchased 
from Cell Signaling. All the other antibodies 
were purchased from Abcam. 
  RNA Extraction and RT-PCR─The cDNA, 
synthesized from the total RNA by a cDNA 
synthesis kit (TaKaRa), was used for 
RT-PCR with a set of primers; 
5’-GCTTACTCCAGGGCTGGCGTTGTGA
AAGACC-3’ and 
5’-AGTCAGCCTCGGGGTAGGTGAAGA
CGAAGG-3’ to analyze c-fos mRNA levels. 
The amplified products were analyzed by 
electrophoresis on an agarose gel. 
  Plasmids ─ The mutant c-fos plasmid, 
pfMC2AT(mt), was constructed from its 
wild-type counterpart, pfMC2AT (25), using 
a PCR-based method with the following 
oligonucleotides to introduce mutations into 
the SRE, FAP-1, and CRE sequences. SRF: 
5’-CTTACACTGTATGTCCCAATCGGGA
CATC-3’ and 
5’-GATGTCCCGATTGGGACATACAGTG
TAAG-3’, FAP-1: 
5’-CCAATCGGGACATCCAACTCAGGC
AGG-3’ and 
5’-CCTGCCTGAGTTGGATGTCCCGATT
GG-3’, CRE: 
5’-GGTTGAGCCCGTAAGGCGTACACTC
-3’ and 
5’-GAGTGTACGCCTTACGGGCTCAAGG
-3’.  
The cDNA clones and the expression vectors 
for transcription factors are described (25). 
  Protein Purification─SRF, Elk-1, CREB, 
and ATF1 were purified as described (25). 
Recombinant human histones H2A and H2B 
or H3 and H4 were co-expressed in E. coli as 
H2A/H2B dimers or H3/H4 tetramers, 
respectively. Cells were sonicated in 
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HEG(100) (10 mM Hepes-KOH pH 7.6, 1 
mM EDTA, 10% glycerol, 100 mM NaCl) 
containing 0.1 mM PMSF, 1 mM DTT, 1 
mM sodium metabisulfite, and 2 mM 
benzamidine-HCl. HCl was added to the 
extract to the final concentration of 0.25 M, 
and the mixture was incubated at -20oC for 
30 min. After centrifugation, the supernatant 
was neutralized with 0.25 volume of 2 M 
Tris base and dialyzed against HEGK(100) 
(10 mM Hepes-KOH pH 7.6, 1 mM EDTA, 
10% glycerol, 10 mM KCl, 100 mM NaCl). 
Histones were purified further by a HiTrap 
SP HP column (GE Healthcare) in a linear 
gradient from 0.1 to 2 M NaCl. Histones 
were eluted at ~1.1 M NaCl, and typical 
yields of H2A/H2B dimer and H3/H4 
tetramer were ~25 mg and ~3 mg, 
respectively, per 1 liter of E. coli culture. 
Native core histones were purified from 
suspension culture of HeLa S3 cells. The 
cells were harvested, washed with 
phosphate-buffered saline (PBS), and 
homogenized in the lysis buffer (0.1% Triton 
X-100, 0.25 M sucrose, 10 mM Tris-HCl pH 
7.4, 10 mM sodium butyrate, 4 mM MgCl2) 
containing 0.1 mM PMSF and 2 mM 
benzamidine-HCl. After centrifugation, the 
nuclear pellet was resuspended in the lysis 
buffer. The nuclei were overlayed onto a 
30% sucrose cushion, and after centrifugation, 
the nuclear pellet was washed twice with the 
lysis buffer and once with 0.25 mM EDTA 
pH 8.0. The nuclear pellet was suspended in 
HEG(100), and the native core histones were 
purified further as described for the 
recombinant histones. Human His-tagged 
NAP-1 was expressed in insect cells and 
purified from the cytoplasmic fraction by 
Phenyl Sepharose and HiTrap Q columns 
(GE Healthcare). FLAG-tagged human 
Topoisomerase I (Topo I) was expressed in 
insect cells and purified by SP Sepharose and 
Hydroxyapatite columns. Drosophila ACF1 
and ISWI were co-expressed in insect cells 
and purified by HiTrap SP, HiTrap Q, and 
Mono S columns (GE Healthcare). 
FLAG-tagged p38 MAP kinase was 
co-expressed with a constitutively active 
mutant of MKK6 in E.coli. The activated 
pp38 was purified by a HiTrap Q column and 
anti-FLAG M2 affinity gel (SIGMA). 
FLAG-tagged MSK1 and Aurora B were 
expressed in insect cells and purified with 
ion-exchange columns and anti-FLAG M2 
affinity gel. HMGN1 was expressed in E. 
coli, and the collected cells were sonicated in 
5% perchloric acid. After centrifugation, 
trichloroacetic acid was added to the 
supernatant to the final concentration of 25%, 
and the mixture was incubated at 4oC for 2 h. 
After centrifugation, the pellet was 
resuspended in 0.3 M HCl, and the insoluble 
proteins were removed by centrifugation. 
Then, HMGN1 was precipitated by acetone, 
and the pellet was resuspended in BC(100). 
HMGN1 was further purified by a HiTrap Q 
column. 
  In Vitro Chromatin Assembly ─ The 
template plasmid (0.3 µg) was relaxed in 
advance with 10 ng of Topo I before the 
subsequent chromatin assembly reaction. 
After 0.38 µg of histones and 8.8 µg of 
NAP-1 were mixed and incubated on ice for 
15 min in the assembly buffer (10 mM 
Hepes-KOH pH 7.6, 1 mM EDTA, 10% 
glycerol, 70 mM KCl, 0.3 µg of BSA), the 
relaxed plasmid (0.3 µg), 0.1 µg of 
ACF1/ISWI, 10 ng of Topo I, and 10 µl of 
ATP-regenerating system (213 µM creatine 
phosphate, 21.3 µM ATP, 30 µM MgCl2, 38 
µg creatine kinase) were added to the 
reactions. When the chromatin was used for 
the kinase assays in the presence of [γ-32P] 
ATP, the ATP-regenerating system contained 
0.213 µM ATP. Where indicated, 2.5 or 5.0 
µg of HMGN1 was also included during the 
assembly reaction. The reactions were further 
incubated at 30oC for 2 h and then used for 
DNA supercoiling or MNase assays. 
  In Vitro Chromatin Kinase Assays─The 
chromatin (equivalent to 150 ng of DNA) 
was incubated at 30oC for 1 h with kinases 
(150 ng of MSK1 plus 6.3 ng of pp38 or 150 
ng of Aurora B) and activators (each 0.1 µg) 
in the kinase buffer (10 mM Hepes-KOH 
pH7.9, 100 mM KCl, 10 mM MgCl2, 5% 
glycerol, 0.5 mM Na3VO4) containing 10 µM 
ATP, and 10 µCi of [γ-32P]ATP (Perkin 
Elmer). Then, polyethylenimine (PEI) was 
added to the mixture to the final 
concentration of 0.8%, and after incubation 
on ice for 30 min, the chromatin was 
precipitated and washed in BC(100) (10 mM 
Hepes-KOH pH 7.9, 10% glycerol, and 100 
mM KCl). The precipitate was suspended in 
SDS-PAGE sample buffer, boiled, and 
separated by SDS-PAGE. The 
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phosphorylated histones were detected by 
either autoradiography or immunoblotting 
with an appropriate phospho-specific 
antibody. 
  GST Pull-Down Assays ─ GST and 
GST-SRF, -Elk-1, -CREB, and -ATF1 were 
expressed in insect cells, and the histone tails 
fused to the N terminus of GST were 
expressed in E. coli. The extract from the 
expressed cells was incubated with 
Glutathione Sepharose 4B (GE Healthcare) 
for 1.5 h at 4oC in the binding buffer (10 mM 
Tris-HCl pH 7.3, 1.5 mM MgCl2, 10 mM 
KCl) and then washed extensively in 
BC(100). The amount of extract was adjusted 
so that a roughly equal amount of each 
GST-fusion protein was bound to 
Glutathione Sepharose 4B. The bound GST 
fusion proteins were incubated in BC(100) at 
room temperature at 4oC with either F:MSK1 
or F:Aurora B, which were partially purified 
by a HiTrap Q column. The bound proteins 
were eluted in SDS-PAGE sample buffer, 
resolved by SDS-PAGE and detected by 
immunoblotting with anti-FLAG M2 
antibody. 
  In Vivo ChIP Assays─HeLa S3 cells, 
serum starved and then treated with 10 µg/ml 
anisomycin, were fixed with 1% 
formaldehyde at 37oC for 5 min. HeLa S3 
cells were fixed with 1% formaldehyde at 
37oC for 5min. The cells were washed with 
ice-cold PBS, resuspended in the lysis buffer 
(1% SDS, 10 mM EDTA pH 8.0, 50 mM 
Tris-HCl pH 8.0, 1 mM PMSF, Protease 
Inhibitor Cocktail [SIGMA], 1 mM Na3VO4, 
50 mM NaF and 10 mM sodium butyrate) 
and sonicated. After centrifugation, the 
supernatant was diluted with 10 volumes of 
the ChIP dilution buffer (0.01% SDS, 1.1% 
Triton X-100, 1.2 mM EDTA, 16.7 mM 
Tris-HCl pH 8.0, 167 mM NaCl, Protease 
Inhibitor Cocktail [SIGMA], 1 mM Na3VO4, 
50 mM NaF and 10 mM sodium butyrate). 
The supernatant was cleared at 4oC for 3 h 
with 20 µl of protein A agarose (50% 
slurry)(GE Healthcare Bioscience) in 0.2 
mg/ml sonicated salmon sperm DNA, 0.5 
mg/ml BSA, 5 mM Tris-HCl pH 8.0, 0.5 mM 
EDTA and 0.025% sodium azide. After 
centrifugation, an appropriate antibody was 
added to the supernatant and the mixture was 
incubated at 4oC overnight. Then, 10 µl of 
protein A agarose was added and the mixture 
was further incubated at 4oC for 3 h. The 
protein A agarose was washed first in Low 
Salt Buffer (0.1% SDS, 1% Triton X-100, 2 
mM EDTA pH 8.0, 20 mM Tris-HCl pH 8.0 
and 150 mM NaCl), second in High Salt 
Buffer (0.1% SDS, 1% Triton X-100, 2 mM 
EDTA, 20 mM Tris-HCl pH 8.0 and 500 mM 
NaCl), third in LiCl Buffer (0.25 M LiCl, 1% 
NP-40, 1% deoxycholate, 1 mM EDTA pH 
8.0 and 10 mM Tris-HCl pH 8.0), and finally 
in TE buffer (10 mM Tris-HCl pH 8.0 and 1 
mM EDTA). The bound DNA was eluted in 
10 mM DTT, 10% SDS and 0.1 M NaHCO3 
at room temperature. The eluted DNA 
samples were pooled and heated at 65oC for 
at least 6 h in 0.2 M NaCl to reverse the 
formaldehyde crosslinking. DNA fragments 
were treated with proteinase K, extracted 
with phenol/chloroform and precipitated with 
ethanol. The obtained DNA was analyzed by 
real-time PCR with a set of primers for the 
c-fos promoter regions 
(5’-CGCGAGCAGTTCCCGTCAATCCCT-
3’, 
5’-GAATGAGTGTAAACGTCACGGGCT
C-3’) and the β-globin coding region 
(5’-GCTGCTGGTTGTCTACCCTTGGAC-
3’, 
5’-CACTGAGGCTGGCAAAGGTGCCCT-
3’). PCR reactions were performed with 
SYBR Green PCR Master Mix (Applied 
Biosystems), and the products were analyzed 
in ABI Prism 7900 Sequence Detector 
System (Applied Biosystems). 
  In Vitro ChIP Assays─ In vitro ChIP 
assays were performed essentially as 
described for in vivo ChIP assays, except that 
formaldehyde cross-linking and sonication 
were not used. Instead, the chromatin was 
digested with MNase at 37oC for 10 min, and 
the digested sample was then diluted with 10 
volumes of the ChIP dilution buffer before 
immunoprecipitaion. The recovered DNA 
samples were analyzed with a set of primers 
for the c-fos promoter as shown above and 
for the vector region 
(5’-GGATTAGCAGAGCGAGGTATGTAG
G-3’, 5’-TTTCGTTCCACTGAGCGTCA 
GACCC-3’). 
 
RESULTS 
 
  Increased Occupancy of MSK1 on the 
c-fos Promoter upon Induction of c-fos Gene 
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Transcription ─ As a first step toward 
analyzing the mechanisms of histone H3 
phosphorylation during transcriptional 
activation, we chose the induction of c-fos 
gene transcription by anisomycin as a model 
system. As reported previously (3,26), 
anisomycin treatment (10 µg/ml or 25 ng/ml) 
of HeLa cells induced c-fos transcription, 
with higher concentration (10 µg/ml) of 
anisomycin eliciting a more sustained c-fos 
transcription (Fig. 1A). Using HeLa cells 
treated with 10 µg/ml of anisomycin, we 
performed chromatin immunoprecipitation 
(ChIP) assays to monitor the phosphorylation 
of serine 10 in histone H3 (H3-S10), 
recruitment of MSK1, and phosphorylation 
of CREB/ATF1 on the c-fos promoter. 
Phosphorylated serine 10 in histone H3 
(H3-S10P) appeared within 15 min after 
anisomycin treatment, peaked at 30 min, and 
continued to show a several-fold increase 
until 90 min (Fig. 1B). The occupancy of 
MSK1 peaked only 15 min after anisomycin 
treatment, apparently preceding the 
phosphorylation of H3-S10 (Fig. 1C). 
Consistent with its role in phosphorylating 
CREB/ATF1 (18,19), the occupancy of 
MSK1 also preceded that of phosphorylated 
CREB/ATF1 (pCREB/pATF1), which 
continued to increase until 60 min after 
anisomycin treatment (Fig. 1C). These results 
demonstrate that MSK1 is actively recruited 
to the c-fos promoter before the appearances 
of pCREB/pATF1 and H3-S10P on the c-fos 
chromatin. 
 
  Chromatin Precludes Histone H3 
Phosphorylation by MSK1─To recapitulate 
MSK1-mediated phosphorylation of histone 
H3 within the chromatin in vitro, we first 
prepared MSK1 and its inactive mutant, 
D195A/D565A, as well as Aurora B 
(supplemental Fig. S1). Fig. 2A indicates that 
MSK1 and Aurora B phosphorylated histones 
H3 (lanes 4 and 8) as well as H2B (lanes 3 
and 7) and, to a lesser extent, histone H4 
(lanes 4 and 8). The contribution of 
contaminating kinases to the observed 
phosphorylations was ruled out because no 
phosphorylation was detected when the 
kinase-deficient MSK1 mutant, 
D195A/D565A, was used (Fig. 2A, lanes 5 
and 6). The immunoblots using anti-S10P 
and anti-S28P antibodies confirmed that 
MSK1, and Aurora B phosphorylated both 
S10 and S28 in histone H3 (lanes 4 and 8). 
  Next, chromatin was reconstituted on a 
c-fos promoter plasmid, pfMC2AT (25), via 
the ACF-based chromatin assembly system 
using recombinant core histones 
(supplemental Fig. S2A and B). The 
recombinant core histones, which were 
devoid of posttranslational modifications 
such as phosphorylation, acetylation, and 
methylation (supplemental Fig. S2E), 
produced a highly regular array of 
nucleosomes, as opposed to the HeLa 
cell-derived core histones (supplemental Fig. 
S2C and D). Moreover, the regularity of 
nucleosomes was not affected by the G-less 
cassette in pfMC2AT. Using the 
reconstituted c-fos chromatin, we then asked 
whether MSK1 and Aurora B phosphorylate 
histone H3 within the context of the 
chromatin. The assembled c-fos chromatin 
was incubated with the indicated kinase in 
the presence of 32P-ATP and precipitated by 
polyethyleneimine (PEI) to remove 
unincorporated 32P-ATP. The precipitated 
chromatin was then separated by SDS-PAGE 
and autoradiographed. As shown in Fig. 2C, 
MSK1 seemed to phosphorylate histone H3 
embedded within the chromatin to a very 
small extent (upper panel, lane 2). Unlike 
MSK1, however, Aurora B phosphorylated 
histone H3 within the chromatin relatively 
well (Fig. 2C, upper panel, lane 4). To 
explore a mechanistic basis for their 
differential sensitivities to the chromatin, we 
tested the interactions between each kinase 
and the N-terminal tails of core histones. 
GST pull-down assays revealed that Aurora 
B interacted with the N-terminal tails of all 
four histones (Fig. 2D, lanes 7-10), whereas 
MSK1 failed to do so under the same 
condition (Fig. 2D, lanes 3-6). Together, our 
results show that the chromatin structure 
presents a strong barrier to the 
MSK1-mediated phosphorylation of histone 
H3; however, Aurora B appears to overcome 
this barrier relatively well, presumably 
through its direct interactions with the 
histone tails.  
 
  MSK1 Phosphorylates Histone H3 at 
Ser10 in an Activator-Dependent Manner─
In view of the poor MSK1-mediated 
phosphorylation of histone H3 within the 
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c-fos chromatin, we wondered whether 
MSK1 requires factors that assist its 
interactions with histones in the context of 
chromatin. Because prime candidates for 
directing MSK1 to histone H3 within the 
c-fos chromatin are activators including SRF, 
Elk-1, CREB, and ATF1, we examined their 
effect on histone H3 phosphorylation by 
MSK1. When the activators were included in 
the reactions, MSK1 phosphorylated histone 
H3 within the chromatin noticeably better 
than in the absence of the activators (Fig. 3A, 
lanes 2-4). Interestingly, this activator 
dependence was observed for additional 
phosphorylation, possibly of histone H2A 
(Fig. 3A, lane 4), which may represent 
another physiologically important 
phosphorylation site (27). The observed 
phosphorylations were specific to the 
intrinsic kinase activity of MSK1 because the 
kinase-deficient MSK1, D195A/D565A, 
displayed no phosphorylation of histones 
(Fig. 3A, lane 5). In marked contrast, Aurora 
B phosphorylated chromatin-embedded 
histone H3 relatively well regardless of the 
presence of the activators (Fig. 3A, lanes 6 
and 7). 
  To determine whether MSK1 
phosphorylates histone H3 at the 
physiologically relevant residues, S10 and 
S28, in response to the activators, 
immunoblot analyses were performed using 
antibodies that specifically recognize 
H3-S10P or H3-S28P. As shown in Fig. 3B, 
MSK1 phosphorylated H3-S10 clearly in the 
presence of the activators, but only 
marginally in their absence (lanes 3 and 4). 
This phosphorylation of H3-S10 required the 
intact kinase domain of MSK1, indicating 
that the phosphorylation of H3-S10 is 
specific (Fig. 3B, lane 5). Aurora B 
phosphorylated H3-S10 to a greater extent 
than MSK1 did, albeit in a completely 
activator-independent manner (Fig. 3B, lanes 
6 and 7). Interestingly, despite their strong 
activity toward S28 in free histone H3, both 
kinases did not phosphorylate H3-S28 to 
detectable levels in the context of chromatin. 
This predominant phosphorylation of H3-S10 
over H3-S28 by MSK1 was further 
corroborated by the quantitative analyses of 
32P-labeled histone H3 on the chromatins 
reconstituted with histone H3 mutant that 
harbors serine-to-alanine mutation(s); namely, 
S10A, S28A or S10A/S28A (Fig. 3C and D). 
As quantified in Fig. 3D, the overall level of 
MSK1-mediated phosphorylation of histone 
H3 was reduced markedly by the S10A 
mutation but not by the S28A mutation, 
indicating that MSK1 phosphorylates histone 
H3 at S10 but not S28 within the chromatin. 
Likewise, the levels of phosphorylation of 
H3-S10A and H3-S10A/S28A were 
comparative (Fig. 3D), again indicating the 
absence of S28 phosphorylation. The residual 
phosphorylation of S10A/A28A also suggests 
a potential phosphorylation site in histone H3 
(Fig. 3D) although its significance remains to 
be determined. Together, these results 
demonstrate that the activators on the c-fos 
chromatin permit MSK1 to phosphorylate 
histone H3 at S10 but not S28 and that the 
S10 phosphorylation occurs independently of 
the phosphorylation status of S28. 
  Given the role of the activators for 
MSK1-mediated H3 phosphorylation, we 
asked whether MSK1 interacts directly with 
the activators. As shown in Fig. 3E, GST 
pull-down assays demonstrated that MSK1 
interacted with all the four activators with 
variable affinities. The strongest interaction 
with MSK1 was observed for Elk-1, followed 
by SRF and CREB, whereas the interaction 
of MSK1 with ATF1 was reproducibly the 
weakest. These results demonstrate that, in 
contrast to Aurora B, MSK1 phosphorylates 
histone H3 at S10 by virtue of its interactions 
with the activators. 
 
  HMGN1 Enhances Activator-Dependent 
Histone H3 Phosphorylation by MSK1─
HMGN1 is a nucleosome-binding protein, 
which decompacts chromatin and is 
associated with actively transcribed genes 
(28,29). Because HMGN1 is phosphorylated 
by MSK1/2 when c-fos is induced (4), we 
explored whether HMGN1 has a direct effect 
on MSK1-mediated histone H3 
phosphorylation. Recombinant HMGN1, 
expressed in and purified from E. coli 
(supplemental Fig. S3A), served as an 
efficient substrate for phosphorylation by 
MSK1 (supplemental Fig. S3B). Consistent 
with the previous study (30), the purified 
HMGN1 could be incorporated efficiently 
into the chromatin and increased the interval 
between nucleosomes (Fig. 4A, arrows), an 
effect that is consistent with its role in 
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chromatin decompaction. To obtain 
additional evidence of HMGN1 incorporation 
into the chromatin, we precipitated the 
assembled chromatin with PEI, a positively 
charged polymer that binds DNA but not 
histones and HMGN1 (Fig. 4B). Fig. 4C 
shows that PEI precipitated not only the 
histones that were assembled into chromatin 
but HMGN1 as well, further confirming that 
HMGN1 was indeed incorporated into the 
assembled chromatin. An SDS-PAGE 
analysis revealed that the precipitated 
chromatin contained roughly equivalent 
moles of HMGN1 and core histones (Fig. 
4C), consistent with the incorporation of two 
HMGN1 molecules per each nucleosome 
(30,31). 
  Next, we examined the effect of the 
incorporated HMGN1 on the phosphorylation 
of chromatin. As shown in Fig. 4D, MSK1 
phosphorylated histone H3 in response to the 
activators to a greater extent on the chromatin 
with HMGN1 than that without HMGN1 
(lanes 3 and 7), indicating that HMGN1 
facilitates MSK1-mediated phosphorylation 
of histone H3. Interestingly, MSK1 
phosphorylated chromatin-bound HMGN1 
quite efficiently regardless of the presence of 
activators (Fig. 4C, lanes 6 and 7). 
Nonetheless, there appeared a slight increase 
in the phosphorylation of HMGN1 in the 
presence of the activators (Fig. 4D, lanes 6 
and 7), suggesting that some residue(s) of 
HMGN1 may be phosphorylated in an 
activator-dependent manner as well. Overall, 
these results indicate that HMGN1 directly 
enhances MSK1-mediated histone H3 
phosphorylation and also suggest a possible 
role for some phosphorylated residues of 
HMGN1 in the histone H3 phosphorylation. 
 
  Histone H3 Phosphorylation by MSK1 
Occurs Preferentially on the Promoter 
Proximal Region─Given the requirement of 
the activators in MSK1-mediated H3-S10 
phosphorylation, we performed in vitro ChIP 
assays to analyze whether H3-S10P is 
localized to the c-fos promoter region, where 
SRF, ATF1, CREB, and ATF1 are present. 
Following the in vitro chromatin kinase 
assays, the chromatin was digested by 
MNase and precipitated by an antibody 
against either histone H3 or H3-S10P, and 
then the precipitated DNA was subjected to 
real-time PCR using sets of primers for the 
promoter region as well as the vector region 
located opposite from the promoter (A or B 
in Fig. 5A). As shown in Fig. 5B, MSK1 
phosphorylated H3-S10 around the promoter 
region slightly more efficiently than the 
vector region. In contrast, Aurora B 
phosphorylated H3-S10 with little regional 
preference, albeit at a higher efficiency (Fig. 
5B). Although the observed regional 
specificity for MSK1-mediates H3-S10 
phosphorylation was unexpectedly small, this 
difference may be significant in view of the 
atomic force microscopic observation that the 
nucleosomes on the opposite side of a 
chromatin reconstituted on a typical circular 
plasmid are not necessarily remote from each 
other and could often be in close proximity to 
each other (32). 
  To further validate the role of the 
activators in recruiting MSK1 to the 
promoter region, we used a c-fos template 
with mutated SRE, FAP-1, and CRE that do 
not bind the activators. ChIP assays showed 
that the mutant template did not bind the 
activators (ATF1/CREB and Elk-1) and 
failed to recruit MSK1 to the template (Fig. 
6C). Moreover, MSK1 did not phosphorylate 
H3-S10 on the mutant c-fos template even in 
the presence of the activators, indicating that 
the activators must be bound to their cognate 
sites to elicit MSK1-mediated H3-S10 
phosphorylation (Fig. 5D). In contrast, 
Aurora B phosphorylated H3-S10 on both 
wild-type and mutant c-fos templates to 
comparable levels, indicating that the 
phosphorylation of H3-S10 by Aurora B is 
not influenced by the activators (Fig. 5D). 
Together, these experiments indicate that the 
activators bound on their cognate sites recruit 
MSK1 to the promoter and allow preferential 
phosphorylation of histone H3 at S10 near 
the promoter. 
 
  Phosphorylation of S133 in CREB is 
Essential for the Phosphorylation of H3-S10
─Having demonstrated the role of activators 
in directing MSK1 to phosphorylate H3-S10, 
we determined which of the four activators 
are essential for this process. Fig. 6A shows 
that only the omission of CREB reduced the 
MSK1-medated H3-S10 phosphorylation 
significantly, although it reduced HMGN1 
phosphorylation only marginally (lane 5). 
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ATF1 also had a small effect in the 
MSK1-medated H3-S10 phosphorylation 
because the simultaneous omission of CREB 
and ATF1 reduced the phosphorylation more 
than the omission of CREB alone (Fig. 6A, 
lanes 5 and 8). In contrast, MSK1 
phosphorylated H3-S10 efficiently regardless 
of the presence of SRF and Elk-1 (Fig. 6A, 
lanes 3, 4 and 7). These results indicate that 
CREB is the predominant transcription factor 
that directs the MSK1-mediated histone H3 
phosphorylation. 
  Because the activators become 
phosphorylated together with the 
phosphorylation of H3-S10 during c-fos 
induction in vivo (Fig. 1C), we asked whether 
the phosphorylations of the activators are 
functionally related to that of histone H3. 
Although the activators obtained from insect 
cells were partially phosphorylated, the 
purified activators could be further 
phosphorylated by MSK1 in vitro. For 
instance, partially phosphorylated S383 in 
Elk-1, S133 in CREB, and S63 in ATF1 
could be phosphorylated further by MSK1 in 
vitro in the absence (Fig. 6B, lanes 1-6) or 
presence (Fig. 6B, lanes 7-9) of the c-fos 
chromatin. To test the functional roles of 
these and other phosphorylations, we mutated 
the following amino acid residues that 
become phosphorylated upon cell stimulation 
into an alanine: namely, S77, S79, S83, S85, 
and S103 in SRF (33,34); T363, T368, S383, 
and S389 in Elk-1 (35); S133 in CREB (36); 
and S63 in ATF1 (37). When the 
phosphorylation-defective activators were 
used in place of their respective wild-type 
counterparts, S133A strongly inhibited the 
phosphorylation of histone H3 (Fig. 6C, lane 
5), and S63A reduced the phosphorylation 
slightly. Notably, S133A also eliminated the 
low background phosphorylation observed 
when the reactions contained MSK1 but not 
the activators (Fig. 6C, lanes 1 and 5), 
indicating that S133A may inhibit the kinase 
activity of MSK1 in a dominant negative 
manner. Consistent with the dispensability of 
SRF and Elk-1 (Fig. 6A), 
phosphorylation-defective SRF and Elk-1 
also did not affect the histone H3 
phosphorylation at all (Fig. 6C, lanes 3, 4, 
and 7). Taken together, these experiments 
make it highly likely that the phosphorylation 
of CREB at S133 and, to a lesser extent, 
ATF1 at S63 serves as a regulatory cue for 
MSK1-mediated H3-S10 phosphorylation. 
 
  MSK1 is Subject to Both Positive and 
Negative Auto-Regulation for 
Phosphorylating Chromatin-Embedded 
Histone H3─MSK1 is one of unique kinases 
that possess two kinase domains termed N- 
and C-terminal kinase domain (NTKD and 
CTKD) (15,17). Because MSK1 appears to 
phosphorylate HMGN1 and histone H3 
concomitantly during c-fos induction (4), we 
hypothesized that each kinase domain may be 
dedicated to phosphorylate separate 
substrates. We also wondered whether one of 
the kinase domains may be dispensable for 
phosphorylating free histones but not for 
chromatin-embedded histones. To test these 
hypotheses, we constructed three MSK1 
mutants, each of which lacks N-terminal 
kinase activity (D195A), C-terminal kinase 
activity (D565A) or both kinase activities 
(D195A/D565A) (Fig. 7A). Similar to 
D195A/D565A, both D195A and D565A lost 
the kinase activity toward free and 
chromatin-bound histones alike (Fig. 7B). 
Likewise, D195A and D565A completely 
lost its kinase activity toward 
chromatin-bound HMGN1 (Fig. 7B). These 
results indicate that the both N- and 
C-terminal kinase activities are necessary for 
phosphorylating different substrates and for 
both free and chromatin-embedded histones. 
  Previous studies on MSKs or their related 
RSKs revealed that their activities are 
regulated by a complex relay of 
phosphorylations (15,17,38-41). Such an 
elaborate activation mechanism implies that 
the phosphorylation of histone H3 within the 
chromatin may be under a similarly intricate 
regulation as well. To explore this, we 
constructed a series of MSK1 deletion 
mutants (Fig. 7E) and examined their 
activities for phosphorylating free and 
chromatin-bound histones (Fig. 7C and D). 
Deletion of the C-terminal region up to the 
CTKD (Δ601-802) slightly diminished the 
kinase activity; however, complete removal 
of the CTKD (Δ421-802) recovered a kinase 
activity, which elicited spurious 
phosphorylation of histone H4 (Fig. 7C). 
These experiments show that the NTKD is 
the kinase activity that directly 
phosphorylates free histones, that the CTKD 
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regulates the activity and, to some extent, the 
substrate specificity of the NTKD, and that 
the NTKD is constitutively repressed by the 
CTKD unless the latter is activated. Further 
removal of the linker region (Δ356-804) 
virtually eliminated the kinase activity (Fig. 
7C), consistent with the essential role of the 
linker region for the NTKD activity (20,42). 
Deletion of the NTKD, on the other hand, 
completely abolished the kinase activity 
(Δ1-343), consistent with the notion that the 
NTKD is the kinase domain of the whole 
MSK1 protein (Fig. 7C). Of special note in 
these analyses is Δ1-41, which lacks only 41 
N-terminal amino acid residues but exhibited 
an activity much higher than wild-type 
MSK1, with the ability to promiscuously 
phosphorylate histone H4 (Fig. 7C). These 
experiments revealed that, in addition to the 
CTKD (residues 431-600), the N-terminal 41 
residues and the region between residues 601 
and 802 play regulatory roles as well. 
  We then tested the above MSK1 mutants 
for their ability to phosphorylate histone H3 
and HMGN1 in the context of the c-fos 
chromatin. As is evident from Fig. 7D, none 
of the deletion mutants phosphorylated 
histone H3 in an activator-dependent manner, 
indicating that almost all regions of MSK1 
are required for the proper phosphorylation 
of histone H3 within the c-fos chromatin. 
Interestingly, Δ421-804 could phosphorylate 
HMGN1, but not histone H3, within the 
chromatin regardless of the presence of the 
activators (Fig. 7D, lanes 11 and 12). 
Moreover, Δ1-41 phosphorylated histone H3 
extremely efficiently regardless of the 
presence of the activators (Fig. 7D, lanes 21 
and 22) as if the chromatin structure 
presented no barrier whatsoever to this 
particular mutant, an activity that is 
reminiscent of Aurora B. Furthermore, Δ1-41 
phosphorylated HMGN1 much better than 
wild-type MSK1 did (Fig. 7D, lanes 21 and 
22), indicating that this mutant has 
completely lost the regulatory mechanism 
when phosphorylating substrates in the 
context of chromatin. 
  To further understand the complex 
regulatory mechanism, we tested the 
interactions between CREB and the deletion 
mutants of MSK1 (Fig. 7E). GST pull-down 
experiments with a series of MSK1 deletion 
mutants revealed that CREB-interaction 
domains were located in the residues 1-41 
and 601-802. In addition, gradual N-terminal 
deletion of MSK1 revealed that the 
C-terminal CREB-interaction domain 
(residues 601-802) was under regulation by 
two regions between residues 42 and 344 and 
between residues 1 and 42; the 
CREB-interaction domain (residues 601-802) 
was strongly repressed by the regions 
between 42 and 344, which in turn was 
counteracted by the N-terminal 41 amino 
acids. The presence of two CREB-interaction 
regions (residues 1-42 and 601-802) is 
consistent with the fact that MSK1 requires 
the N- and C-terminal regions that are located 
outside the canonical kinase domains to 
phosphorylate histone H3 within the 
chromatin in response to activators (Fig. 7D). 
  In sum, in addition to the well-known 
regulation of the NTKD by the CTKD, 
MSK1 possesses a network of both positive 
and negative auto-regulations with regards to 
the overall kinase activity and CREB 
interactions (Fig. 7F). These auto-regulatory 
networks within MSK1 seem to be exploited 
by CREB via protein-protein interactions to 
regulate histone H3 phosphorylation within 
chromatin. 
 
DISCUSSION 
 
  In this study, we demonstrate that CREB 
and its phosphorylation at S133 play a 
pivotal role in MSK1-mediated histone H3 
phosphorylation, which is augmented by 
HMGN1. Earlier studies in vivo strongly 
implicated the role of CREB and HMGN1 in 
regulating the MSK1-mediated 
phosphorylation of histone H3 at the 
promoters of immediate early genes 
(4,19,20,24,43-45). In particular, 
MSK1/MSK2 double knockout cells show 
that the kinases are essential for the 
stress-induced phosphorylations of CREB 
and ATF1 and that lack of both kinases 
results in a 50% reduction in c-fos mRNA 
induction (19). Moreover, in these cells 
histone H3 and HMGN1 phosphorylations 
were severely diminished or abolished (4). 
Likewise, HMGN1 knockout cells show that 
HMGN1 modulates histone H3 
phosphorylation upon anisomycin treatment 
(44). Our biochemical analyses not only 
corroborate these in vivo studies but also 
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provide molecular insights into the regulatory 
mechanisms that underlie histone H3 
phosphorylation by MSK1. 
 
  MSK1 Recruitment to the c-fos Promoter
─MSK1, like its closely related MSK2, 
possesses two NLS within its CTKD and is 
localized almost exclusively within nucleus 
(15). Despite its nuclear localization, 
however, it is implausible that MSK1 is 
continuously associated with chromatin. 
Indeed, the occupancy of MSK1 on the 
endogenous c-fos promoter increases 
dramatically upon c-fos gene induction but 
promptly decreases thereafter (Fig. 1C)(46); 
moreover, MSK1 does not interact stably 
with the N-terminal tails of core histones in 
our GST pull-down assays (Fig. 2D). In view 
of these observations, MSK1 may be actively 
recruited to—and perhaps removed 
from—the c-fos chromatin in vivo. Active 
recruitment of kinases has been documented 
for other kinases as well (47), including the 
Hog1 kinase, which is a yeast MAP kinase 
involved in osmotic stress response (48). 
Such kinases are now considered to be a 
transient but active component of the 
transcriptional machinery (49) and to regulate 
a broad range of transcriptional processes 
that occur on chromatin (50,51). For instance, 
the Hog1 kinase, once recruited to the 
promoter, facilitates subsequent recruitment 
of RNAPII (51), the Rpd3 histone 
deacetylase complex (52) and the RSC 
chromatin remodeling complex (53). 
  The recruitment of MSK1 and the 
subsequent phosphorylation of H3-S10 on 
the c-fos chromatin requires CREB and, to a 
lesser extent, ATF1, but surprisingly not SRF 
and Elk-1 (Fig. 6). Relevant to this result, a 
study on MSK1/2 double knockout cells 
reported that anisomycin-induced 
transcription is markedly reduced in 
CRE-dependent IE genes such as c-fos but 
not in SRE-dependent IE genes such as egr-1 
(19). Moreover, transcriptional induction of 
Nur77, which is mainly mediated via CREB 
bound to the two AP-1-like elements on the 
Nur77 promoter, depends strongly upon the 
activation of MSK1/2 (54). Thus, these 
results argue strongly for an intimate 
functional relationship between MSK1/2 and 
CREB/ATF1. An important question, then, 
concerns how MSK1 selectively utilizes 
CREB and ATF1 as a platform for 
phosphorylating histone H3 within the 
chromatin. The simplest notion is that only 
CREB and ATF1 interact specifically with 
MSK1 and recruit it to the chromatin and that 
the MSK1 recruitment is sufficient for 
subsequent histone H3 phosphorylation. This 
notion, however, seems unlikely because 
MSK1 interacts with SRF and Elk-1 even 
better than CREB and ATF1 (Fig. 3E), and 
Elk-1 does recruit MSK1 to the c-fos and 
egr-1 promoters in vitro and in vivo (46). 
Instead, in view of the complex functional 
and physical interplays between CREB and 
MSK1 (Fig. 7), it is more plausible that only 
a certain type of activators interact with 
MSK1 in a manner that is conducive to 
MSK1-mediated histone H3 phosphorylation. 
Because anisomycin-stimulated cells show a 
punctate distribution of H3-S10P within 
nucleus (5) and a mere fraction of histone H3 
becomes phosphorylated in these cells (7,55), 
activators that assist MSK1 to phosphorylate 
H3-S10 may include a fairly small number of 
activators. 
  Additional requirement for 
MSK1-mediated H3-S10 phosphorylation on 
the c-fos chromatin is that CREB must bind 
DNA and be phosphorylated at S133 (Figs. 5 
and 6). Although more rigorous analyses are 
required to determine the exact temporal 
order of CREB and H3-S10 phosphorylations, 
it would be mechanistically logical to assume 
that CREB becomes phosphorylated at S133 
before it facilitates the phosphorylation of 
H3-S10. Given that the phosphorylation of 
S133 induces an alteration in the structure of 
CRE-bound CREB but not that of free CREB 
(56), this structurally altered pCREB bound 
to the CRE may be an essential platform 
whereby MSK phosphorylates H3-S10 on the 
c-fos chromatin. 
  Finally, although both H3-S10 and H3-S28 
are phosphorylated upon cell stimulation by 
MSK1/2 (4), recent analyses revealed that 
each phosphorylation occurs in spatially 
segregated locations within nucleus (45,57). 
In our kinase assays using the c-fos 
chromatin, MSK1 does not phosphorylate 
H3-S28 to a detectable level although MSK1 
phosphorylates free histone H3 at both S10 
and S28 (Figs. 2 and 3). We suspect that the 
S28 phosphorylation within the chromatin 
may require additional modification(s) of 
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histone H3 or some activators other than 
CREB and ATF1. Such modifications or 
activators, however, remain to be identified. 
 
  Chromatin Structure and Histone H3 
Phosphorylation ─ Chromatin imposes a 
strong barrier to the reactions that occur on 
DNA and also impedes accessibility to 
histones within nucleosomes. Even the 
N-terminal tails of histones, which protrude 
from the nucleosome, are not necessarily 
accessible. For example, a histone 
acetyltransferase GCN5 can acetylate the 
N-terminal tails of free histones but not those 
of histones within chromatin (58,59) unless it 
is complexed as the SAGA complex (59). 
Likewise, MSK1 phosphorylates the tails of 
free histones efficiently, yet its 
phosphorylation of histone tails within 
chromatin is far less efficient (Fig. 2). 
  This intrinsic nucleosomal barrier appears 
to be modulated to some extent by HMGN1, 
an architectural chromatin protein that binds 
to nucleosomes and decompacts chromatin 
(29,60,61). Although Lim et al. reported that 
HMGN1 diminishes the MSK1-mediated 
phosphorylation of histone H3 within a 
nucleosome core particle (44), our assays 
show that HMGN1 enhances the 
MSK1-mediated histone H3 phosphorylation 
in an activator-dependent manner on a 
reconstituted nucleosome array—a more 
physiological context in which HMGN1 
interacts with nucleosomes in vivo. 
Nevertheless, both in vitro studies agree in 
that HMGN1 has a certain degree of 
influence on the phosphorylation of histone 
H3 by MSK1. Together with the concurrent 
appearance of HMGN1 and H3-S10 
phosphorylations upon cell stimulation (7), 
the regulation of histone H3 phosphorylation 
may involve HMGN1 and, possibly, its 
phosphorylation by MSK1. 
  HMGN1 consists of multiple domains 
including the nucleosomal binding domain 
and chromatin unfolding domain (60,61). 
Because the chromatin unfolding domain is 
located near—and probably interacts 
with—the residues 20-50 of histone H3 (62), 
this domain may directly shift the position of 
the histone H3 tail in a manner that would 
facilitate H3-S10 phosphorylation by MSK1. 
Moreover, MSK1 phosphorylates HMGN1 at 
S20 and S24, two serine residues that are 
critical for the interaction of HMGN1 with a 
nucleosome (44). Because the 
phosphorylations of S20 and S24 have a 
marked impact on the HMGN1-nucleosome 
interaction (44,63), they may provide an 
additional regulatory mechanism to the 
H3-S10 phosphorylation by MSK1. 
 
  Intra- and Inter-Molecular Regulations of 
MSK1-Mediated Histone H3 
Phosphorylation ─ MSK1 possesses two 
kinase domains, termed the NTKD and 
CTKD, which are connected by a linker 
region (15,17). Consistent with the regulatory 
role for the CTKD, the isolated CTKD does 
not phosphorylate free or 
chromatin-embedded histone H3, further 
confirming its role only as the regulator of 
the NTKD even in the chromatin-based 
assays (Fig. 7). Because the activity of the 
NTKD can be repressed in a dominant 
negative manner by the kinase-deficient 
CTKD, the CTKD functions as a positive as 
well as negative regulator of the NTKD. In 
addition to the regulation by the CTKD, this 
study revealed another major regulation by 
the region between residues 1-41, which we 
term as the N-terminal inhibition domain 
(NID), located immediately upstream of the 
NTKD. The importance of the NID is two 
fold. First, this region represses the overall 
activity of MSK1, an effect most 
dramatically observed when 
chromatin-embedded histone H3 is used as a 
substrate. Second, the NID is essential for 
CREB-dependent activation of MSK1 in the 
context of chromatin. Indeed, despite a 
region of mere 41 residues, removal of the 
NID is sufficient to convert MSK1 into a 
kinase that phosphorylates 
chromatin-embedded histone H3 
indiscriminately, in a manner akin to Aurora 
B. 
  This regulatory role of the NID is attested 
by a recent structural study on the NTKD of 
MSK1 (64). Smith et al. reported that the 
N-terminal region of MSK1 forms a 
three-stranded β sheet, consisting of the β1L0 
strand (residues 26-32), the βB strand 
(residues 84-91) and the β9 strand (residues 
198-202) and that this structure is unique to 
MSK1 among the AGC family members. 
Because the three-stranded β-sheet keeps the 
ATP-binding site sterically blocked, it serves 
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as an auto-inhibitory structure that holds 
MSK1 in an inactive conformation, a 
mechanism that is entirely in agreement with 
our biochemical results (Fig. 7). Moreover, 
the study predicts that when the NTKD of 
MSK1 is activated, the βB strand would 
change from the β-sheet into an α-helix 
before allowing the entry of ATP into the 
catalytic site. Because the β1L0 strand 
(residues 26-32) overlaps the NID (residues 
1-41), it is tempting to hypothesize that the 
interaction between the NID and CREB 
would displace the β1L0 strand from the βB 
strand. This would convert the βB strand 
from the β-strand into an α-helix, a structural 
transition that is predicted to evoke activation 
of MSK1. 
  Finally, we note that various regulatory 
roles are played by the N-terminal extensions 
in PKB, PRK, and PKC, all of which belong 
to the AGC family kinases that resemble the 
NTKD of MSK1. For example, PKB 
becomes anchored to plasma membrane 
through the interaction with 
phosphoinositides via the PH domain in its N 
terminus (65-68). Similarly, PKC interacts 
with and is activated by diacylglycerol via 
the C1 domain located in its N terminus 
before the kinase is recruited to plasma 
membrane (69-71). PRK becomes activated 
upon its interaction with Rho A via the HR1 
and HR2 motifs located in its N terminus 
(72). Thus, despite their structural diversity, 
the N-terminally extended residues in MSK1, 
PKB, PKC, and PRK—and perhaps other 
members of the AGC family as well—may 
be generally involved in regulating the 
location and/or activity of each kinase. 
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LEGENDS TO FIGURES 
 
FIGURE 1. Histone H3 phosphorylation and MSK1 recruitment on the c-fos promoter in 
response to anisomycin treatment. A, HeLa cells were stimulated by anisomycin with two 
different concentrations (high, 10 µg/ml; low, 25 ng/ml) after starved in 0.5% FBS for 1.5 days. 
The c-fos mRNA was amplified by RT-PCR, followed by electrophoresis on an agarose gel. B, 
HeLa cells were stimulated by anisomycin (10 µg/ml) for the indicated time and used for ChIP 
assays with anti-histone H3 and anti-H3-S10P antibodies. The precipitated DNA was quantified 
by real-time PCR using primers for the c-fos gene. As control, the β-globin gene was used. The 
values were averaged from two independent experiments. C, the occupancies of MSK1 and 
pCREB/pATF1 were determined by ChIP assays using antibodies against MSK1 and 
pCREB(S133), which also recognizes pATF1(S63). The values were averaged from two 
independent experiments. 
 
FIGURE 2. MSK1 does not phosphorylate histones assembled into chromatin. A, the kinase 
assays contained [γ-32P]ATP and 100 ng of recombinant histones with 100 ng of MSK1 (lanes 3 
and 4), D195A/D565A (lanes 5 and 6) or Aurora B (lanes 7 and 8). The position of each histone 
is indicated on the right. B, the identical kinase assays were performed in the absence of 
[γ-32P]ATP, and the phosphorylated residues in histone H3 were identified by immunoblotting 
using anti-H3-S10P and anti-H3-S28P antibodies. C, 150 ng of chromatin assembled on 
pfMC2AT was phosphorylated in the presence of [γ-32P]ATP with 150 ng of MSK1 (lane 2), 
D195A/D565A (lane 3) or Aurora B (lane 4). As control, 10 ng of free H3-H4 tetramer were 
phosphorylated with MSK1 (lane 1). The positions of histone H3 on the autoradiogram (upper 
panel) and the core histones on the SDS-PAGE gel (lower panel) are indicated on the right. D, 
the N-terminal tails of histones fused to GST were retained on Glutathione Sepharose 4B and 
incubated with FLAG-tagged MSK1 (lanes 2-6) or Aurora B (lanes 8-12), and the bound 
proteins were analyzed by immunoblotting using anti-FLAG M2 antibody. The positions of the 
bound MSK1 or Aurora B are indicated on the right. 
 
FIGURE 3. MSK1 phosphorylates serine 10 of histone H3 within chromatin in an 
activator-dependent manner. A, 150 ng of the c-fos chromatin was incubated in the presence 
of 150 ng of MSK1 (lanes 3-5) or Aurora B (lanes 6 and 7) and 100 ng of the four activators 
(lanes 4, 5 and 7) using 10 mM [γ-32P]ATP. D195A/D595A is a kinase-deficient MSK1 (lane 5). 
20 ng of free H3/H4 tetramer was phosphorylated by 400 ng of MSK1 as control (lane 1). The 
gel was stained in CBB (lower panel) and then exposed to an x-ray film (upper panel). B, the 
same sets of reactions as in A were performed in the absence of [γ-32P]ATP, and the 
phosphorylated residues were detected by immunoblotting using anti-H3-S10P (upper panel) or 
anti-H3-S28P (lower panel). C, chromatins assembled with wild-type (lanes 2 and 3) or mutant 
histone H3 whose serine is replaced with an alanine at both S10 and S28 (lanes 4 and 5), S10 
(lanes 6 and 7) or S28 (lanes 8 and 9) were digested with two different concentrations of MNase. 
Molecular weight marker is a 123-bp DNA ladder (lanes 1 and 10). D, kinase reactions were 
performed as in A, using the chromatin reconstituted with wild-type or mutant histones in the 
presence of MSK1 (black bars) or Aurora B (gray bars). The levels of phosphorylation were 
measured by Image Quant software (GE Healthcare). E, GST (lane 2) or GST-fused activators 
(lanes 3-6) bound to Glutathione Sepharose 4B were incubated with FLAG-tagged MSK1, and 
the bound MSK1 was detected by immunoblotting using anti-FLAG M2 antibody. Two % of 
input FLAG-tagged MSK1 was loaded as control (lane 1). 
 
FIGURE 4. HMGN1 enhances MSK1-mediated histone H3 phosphorylation within the 
c-fos chromatin. A, the c-fos plasmid, pfMC2AT, was assembled into chromatin in the 
presence of 0 µg (lane 2), 2.75 µg (lane 3) and 5.5 µg (lane 4) of HMGN1, and then partially 
digested by MNase. The arrows indicate the increased spacing between nucleosomes by 
incorporated HMGN1. B, schematic depiction of chromatin precipitation by PEI. C, chromatin 
was assembled in the presence of 0 µg (lane 1), 2.75 µg (lane 2) and 5.5 µg (lane 3) of HMGN1 
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as in A, precipitated by PEI as in B, resolved by SDS-PAGE, and stained with CBB. The 
positions of precipitated proteins are indicated on the right. D, kinase assays were performed 
with the chromatin assembled in the presence (lanes 5-8) or absence (lanes 1-4) of 5.5 µg of 
HMGN1. The chromatin was incubated in the presence of [γ-32P]ATP with (lanes 1, 3, 4, 5, 7 
and 9) or without (lanes 2 and 6) 100 ng each of activators (SRF, Elk-1, CREB and ATF1). The 
reactions also contained wild-type MSK1 (lanes 2, 3, 6 and 7) or D195A/D565A (lanes 4 and 8). 
The positions of HMGN1 and H3 are indicated on the right. 
 
FIGURE 5. Preferential phosphorylation of histone H3 near the c-fos promoter region. A, 
wild-type (pfMC2AT) and mutant (pfMC2AT(m)) c-fos templates used for in vitro ChIP assays 
and the regions amplified by PCR. The region A overlaps with the c-fos promoter whereas the 
region B is within the vector pUC19 and ~1.5 kb downstream from the transcription start site. B, 
the c-fos chromatin was phosphorylated by MSK1 in the presence of activators or by Aurora B, 
and then analyzed by ChIP assays using anti-H3-S10P. The levels of H3-S10P were normalized 
by the values obtained with anti-histone H3 antibody. The values obtained without any kinase 
were set to 1. C, in vitro ChIP assays for the occupancies of MSK1 and phosphorylated 
activators (CREB, ATF1 and Elk-1). Wild-type (WT) and mutant (mt) c-fos templates were 
assembled into chromatin and the kinase reactions were done in the presence of MSK1 and the 
activators. ChIP assays were performed with antibodies against histone H3, MSK1, 
pCREB(S133) and pElk-1(S383), using the primers for the region A. The anti-pCREB(S133) 
antibody also recognizes pATF1(S63). Gray and white bars indicate the relative amounts of 
histone H3, MSK1 and the activators on the wild-type and mutant templates, respectively. D, 
wild-type and mutant c-fos templates were assembled into chromatin, and the relative levels of 
H3-S10 phosphorylation in the presence of MSK1 or Aurora B were determined by ChIP assays 
using anti-H3-S10P and the primers for the region A. 
 
FIGURE 6. MSK1-mediated chromatin phosphorylation requires phosphorylation of S133 
in CREB. A, the c-fos chromatin was phosphorylated by MSK1 in the presence of various 
combinations of activators. The reactions contained no activator (lane1), SRF, Elk-1, CREB and 
ATF1 (lane 2), Elk-1, CREB and ATF1 (lane 3), SRF, CREB and ATF1 (lane 4), SRF, Elk-1 
and ATF1 (lane 5), SRF, Elk-1 and CREB (lane 6), CREB and ATF1 (lane 7), and SRF and 
Elk-1 (lane 8). The positions of histone H3 and HMGN1 are indicated on the right. B, wild-type 
(WT) or mutant (mt) activators were analyzed by immunoblotting using the indicated 
phospho-specific antibodies. The control reactions (lanes 1-6) contained either wild-type or 
mutant MSK1 and activators in the absence of chromatin, whereas the reactions in lanes 7-9 
were performed in the presence of the c-fos chromatin. C, phosphorylation-defective mutants of 
SRF (lane 3), Elk-1 (lane 4), CREB (lane 5), ATF1 (lane 6), SRF and Elk-1 (lane 7), CREB 
and ATF1 (lane 8) were used in place of the corresponding wild-type activator(s). Control 
reactions contained no activator (lane 1), wild-type activators (lane 2) and mutant activators 
(lane 9). The positions of histone H3 and HMGN1 are indicated on the right. 
 
FIGURE 7. Multiple domains within MSK1 are required for histone H3 phosphorylation. 
A, D195A, D565A or D195A/D565A has an alanine in place of an aspartate at residue(s) 195, 
565 or 195 and 565, respectively. B, histone H3-H4 tetramers (lanes 1-4) or reconstituted 
chromatin (lanes 5-13) were phosphorylated by wild-type (lanes 1, 6 and 7) or mutant MSK1 
(lanes 2-4 and 8-13). MSK was omitted from lane 5. In the chromatin kinase assays, the 
reactions were performed in the presence (+) or absence (-) of activators (SRF, Elk-1, CREB 
and ATF1). Phosphorylated HMGN1 and histones were detected by autoradiography. The 
positions of HMGN1, histone H3 and H4 are indicated on the right. C, histone H3-H4 tetramers 
were phosphorylated by the deletion mutants of MSK1 as depicted in E. The positions of 
histone H3 and H4 are indicated on the right. D, chromatin kinase assays were performed with 
wild-type (lanes 3 and 4) or mutant MSK1 (lanes 5-22) in the presence or absence of activators. 
As controls, free histone H3-H4 tetramers were phosphorylated by wild-type MSK1 (lane 1). 
MSK1 was omitted from lane 2. E, a schematic depiction of MSK1 deletion mutants and the 
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summarized results of C and D as well as those of GST pull-down assays between the MSK1 
mutants and CREB. No phosphorylation or interaction is indicated by -, and the approximate 
levels of phosphorylation or interaction are indicated by the increasing number of +. F, multiple 
intra-molecular regulations control the kinase activity of MSK1 and its interactions with CREB. 
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FIGURE S1. Purified kinases for chromatin kinase assays. A, the p38 kinase was co-expressed with constitutively
active MKK6 in E. coli to obtain its active form, pp38 whereas recombinant MSK1, its inactive mutant, D195A/D565A,
and Aurora B were expressed in insect cells. The expressed kinases were purified to near homogeneity and separated by
SDS-PAGE. The gel was stained with CBB. In D195A/D565A, aspartates at residues 195 and 565 were mutated to an
alanine to inactivate both NTKD and CTKD activities. B, wild-type MSK1 and D195A/D565A (0.5 μg each) were
phosphorylated by 2.5 ng (lanes 2 and 5) or 25 ng (lanes 3 and 6) of pp38 in 35 μM [γ-32P]ATP. The phosphorylated
proteins were detected by autoradiography. The position of MSK1 is indicated on the right. In all the subsequent
experiments using MSK1 or its derivative mutants, ~4.2 ng of pp38 was added per 100 ng of MSK1 to fully activate
MSK1 purified from insect cells.
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Supplemental FIGURE S2
FIGURE S2. Nucleosomes assembled on the c-fos promoter with recombinant histones. A, purified histones
and chromatin assembly factors. Recombinant histones H2A and H2B (lane1), histones H3 and H4 (lane 2), mixture
of histones H2A, H2B, H3 and H4 (lane 3) as well as HeLa cell-derived core histones (lane 4) were analyzed by
SDS-PAGE. The purified chromatin assembly factors including Drosophila ACF1/ISWI, human NAP-1, and human
Topo I were analyzed by SDS-PAGE. B, the 3,420-bp plasmid (pfMC2AT) includes the c-fos promoter (-11~-402)
and a G-less cassette. The positions of the SRE, FAP-1, CRE and the TATA box are indicated. C, the relaxed plasmid
(lane 1) was assembled into chromatin with recombinant (lane 2) or HeLa cell-derived core histones (lane 3), and the
degree of superhelicity was analyzed by electrophoresis on an agarose gel. The positions of nicked, relaxed and
supercoiled plasmids are indicated. D, micrococcal nuclease (MNase) digestion assays. The assembled chromatins
were partially digested at two different concentrations of MNase, and the digested plasmid DNA was analyzed by
electrophoresis on an agarose gel. The marker lane (M) is a 123-bp DNA ladder. E, analyses of posttranslational
modifications of recombinant or HeLa cell-derived histones. Histone modifications were analysed by immunoblot
using antibodies that recognize specifically modified residues within histones. HeLa cell-derived native histones (N)
or recombinant histones (R) were tested for acetylation (Ac) and phosphorylation (P) of the indicated residues. K9Ac,
for example, indicates the acetylated lysine 9.
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Supplemental FIGURE S3
FIGURE S3. Phosphorylation of HMGN1 by MSK1. A, purified recombinant HMGN1 (500 ng) was
analyzed by SDS-PAGE. B, HMGN1 (500 ng) was phosphorylated by MSK1 alone (lanes 1-3) or MSK1
and pp38 (lanes 4-6). The reactions contained 5 ng (lanes 1 and 4), 50 ng (lanes 2 and 5) and 500 ng
(lanes 3 and 6) of MSK1, together with 0.25 ng (lane 4), 2.5 ng (lane 5) and 25 ng (lane 6) of pp38.
The phosphorylation was detected by autoradiography, and the positions of HMGN1 and phosphorylated
MSK1 are indicated on the right.
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FIGURE S4. Purified MSK1 and its mutants. A, D195A, D565A and D195A/D565A
have an alanine in place of an aspartate at residue(s) 195, 565 or both 195 and 565,
respectively. Purified recombinant MSK1 mutants were analyzed by SDS-PAGE. B, a series
of N-terminal and C-terminal deletion mutants were purified and analyzed by SDS-PAGE.
